← All organizations

EA Pharma Co., Ltd.

For profitWebsite ↗

Also known as: EA Pharma Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Feb 1, 2020

Timeline

2010s

Jan 1, 2016
EA Pharma Co., Ltd.— Founded

Drugs by trial phase (11 distinct, 14 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (4 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (14)

NCT04235205CollaboratorPhase 2Feb 1, 2020
NCT04223960Lead sponsorPhase 1Jan 6, 2020
NCT03733314Lead sponsorPhase 2Apr 25, 2019
NCT03922633Lead sponsorPhase 1Apr 22, 2019
NCT03531892Lead sponsorPhase 3Jun 6, 2018
NCT03444818Lead sponsorPhase 1Apr 17, 2018
NCT03390647Lead sponsorPhase 1Dec 21, 2017
NCT03133468Lead sponsorPhase 1May 1, 2017
NCT03092765Lead sponsorPhase 2Mar 21, 2017
NCT03014895Lead sponsorEarly Phase 1Jan 25, 2017
NCT03018054Lead sponsorPhase 2Nov 28, 2016
NCT02961556Lead sponsorPhase 3Nov 15, 2016
NCT02902978Lead sponsorPhase 1Sep 26, 2016
NCT02063854CollaboratorPhase 2/Phase 3Feb 1, 2014

Details

Founded: Tokyo, JP Jan 1, 2016
Last known activity: Feb 1, 2020